Ambio is a specialty pharmaceutical company focused on the development of biosimilar, bioequivalent, and other complex generic drugs. The company has a strong pipeline and strategic partnerships with leading pharmaceutical companies. Ambio has expertise in peptide drug development and manufacturing, and starting in 2024, it plans to launch several biosimilar drugs targeting blockbuster indications. The company is also working ...
Ambio is a specialty pharmaceutical company focused on the development of biosimilar, bioequivalent, and other complex generic drugs. The company has a strong pipeline and strategic partnerships with leading pharmaceutical companies. Ambio has expertise in peptide drug development and manufacturing, and starting in 2024, it plans to launch several biosimilar drugs targeting blockbuster indications. The company is also working on the development of more complex drugs in therapeutic areas such as diabetes and obesity.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.